Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for Beta Bionics, Inc. Common Stock (BBNX).
- Disclosed ownership: 8.6%.
- Date of event: 30 Sep 2025.
MORGAN STANLEY - 30 Sep 2025 SCHEDULE 13G/A Report for Beta Bionics, Inc. Common Stock (BBNX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Security
- Beta Bionics, Inc. Common Stock
- Symbol
- BBNX
- Shares outstanding
- 43,483,337 shares
- Disclosed Ownership
- 3,739,567 shares
- Ownership
- 8.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Nov 2025, 12:01:16 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 07 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 8.6% ownership in Beta Bionics, Inc. Common Stock (BBNX) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 07 Aug 2025.
- Current filing was accepted on 07 Nov 2025, 12:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 8.6% | 3,739,567 | 0 | 3,737,581 | Chris O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 7.8% | 3,384,256 | 0 | 3,384,256 | Chris O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |